Targeted Enteral Nutrient Delivery: A Prospective Randomized Study
NCT03064347 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 19
Last updated 2019-06-18
Summary
This study will evaluate whether enteric-coated nutrients increase some glucose and regulating hormone levels, glucose tolerance and satiety in overweight and obese individuals with type 2 diabetes.
Conditions
- Diabetes Mellitus, Type 2
Interventions
- DIETARY_SUPPLEMENT
-
Sucrose plus Whole Milk Powder in Enteric Coating
Single dose enteric coated sucrose plus whole milk powder will be consumed by mouth. Blood will be drawn at baseline and then at 15 minute intervals for 3 hours from ingestion for measurement of GLP-1, PYY, C-peptide, insulin and glucose.Visual analog score will be used to record satiety and adverse symptoms every 15 minutes.
- DIETARY_SUPPLEMENT
-
Non coated Sucrose plus Whole Milk
Single dose sucrose plus whole milk powder with separate enteric coating materials will be consumed by mouth. Blood will be drawn at baseline and then at 15 minute intervals for 3 hours from ingestion for measurement of GLP-1, PYY, C-peptide, insulin and glucose.Visual analog score will be used to record satiety and adverse symptoms every 15 minutes.
- DIETARY_SUPPLEMENT
-
Sucrose in Enteric Coating
Single dose enteric coated sucrose will be consumed by mouth. Blood will be drawn at baseline and then at 15 minute intervals for 3 hours from ingestion for measurement of GLP-1, PYY, C-peptide, insulin and glucose.Visual analog score will be used to record satiety and adverse symptoms every 15 minutes.
- DIETARY_SUPPLEMENT
-
Sucrose with Separate Enteric Coating Materials
Single dose sucrose with separate enteric coating materials will be consumed by mouth. Blood will be drawn at baseline and then at 15 minute intervals for 3 hours from ingestion for measurement of GLP-1, PYY, C-peptide, insulin and glucose.Visual analog score will be used to record satiety and adverse symptoms every 15 minutes.
- DIETARY_SUPPLEMENT
-
Whey Protein in Enteric Coating
Single dose enteric coated whey protein will be consumed by mouth. Blood will be drawn at baseline and then at 15 minute intervals for 3 hours from ingestion for measurement of GLP-1, PYY, C-peptide, insulin and glucose.Visual analog score will be used to record satiety and adverse symptoms every 15 minutes.
- DIETARY_SUPPLEMENT
-
Whey Protein with Separate Enteric Coating Materials
Single dose whey protein with separate enteric coating materials will be consumed by mouth. Blood will be drawn at baseline and then at 15 minute intervals for 3 hours from ingestion for measurement of GLP-1, PYY, C-peptide, insulin and glucose.Visual analog score will be used to record satiety and adverse symptoms every 15 minutes.
- DIETARY_SUPPLEMENT
-
Pea Protein in Enteric Coating
Single dose enteric coated pea protein will be consumed by mouth. Blood will be drawn at baseline and then at 15 minute intervals for 3 hours from ingestion for measurement of GLP-1, PYY, C-peptide, insulin and glucose.Visual analog score will be used to record satiety and adverse symptoms every 15 minutes.
- DIETARY_SUPPLEMENT
-
Pea Protein with Separate Enteric Coating Materials
Single dose pea protein with separate enteric coating materials will be consumed by mouth. Blood will be drawn at baseline and then at 15 minute intervals for 3 hours from ingestion for measurement of GLP-1, PYY, C-peptide, insulin and glucose.Visual analog score will be used to record satiety and adverse symptoms every 15 minutes.
Sponsors & Collaborators
-
University of Southern California
lead OTHER
Principal Investigators
-
Elizabeth Beale, MD · University of Southern California, Keck School of Medicine
Study Design
- Allocation
- RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- SINGLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-02-22
- Primary Completion
- 2018-06-20
- Completion
- 2018-06-20
Countries
- United States
Study Locations
More Related Trials
-
Effect of Different Protein Diets on Glucose and Insulin Metabolism and Substrate Partitioning
NCT01034241 ·Status: COMPLETED ·Phase: NA
-
The Effect of Whey Protein Consumed as a Pre-meal on Postprandial Lipemia in Healthy and Subjects With Type 2 Diabetes
NCT02343471 ·Status: COMPLETED ·Phase: NA
-
Dose-response Effect of Whey Protein Consumed as Pre-meal on Postprandial Lipaemia in Subjects With Metabolic Syndrome
NCT02087124 ·Status: COMPLETED ·Phase: NA
-
The Role of Protein in Regulating Ad Libitum Energy Intake in Humans
NCT02613065 ·Status: COMPLETED ·Phase: NA
-
The Effect of a High Protein, High Fibre Shake Pre-load on Measures of Satiety and Subsequent Energy Intake
NCT02979717 ·Status: COMPLETED ·Phase: NA
-
Whey Protein Ingestion and Glucose Control in Pre- and Post Diabetic Individuals
NCT06694155 ·Status: RECRUITING ·Phase: NA
-
Enteral Nutrition and Immune Proteins Study
NCT06828094 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Resistant Starch and Whey Protein on Energy Metabolism
NCT02418429 ·Status: COMPLETED ·Phase: NA
-
Gastrointestinal Hormonal Regulation of Obesity
NCT01146704 ·Status: COMPLETED ·Phase: NA
-
Modulation of the Intestinal Microbiome by a High Protein Diet
NCT04812964 ·Status: COMPLETED ·Phase: NA
-
Glycaemic Response and Insulinaemic Response for Nutralys S85 Plus and Whey Protein
NCT04871971 ·Status: COMPLETED ·Phase: NA
-
The Effects of Protein Source on Appetite Control, Satiety, and Subsequent Food Intake
NCT03154606 ·Status: COMPLETED ·Phase: NA
-
Effect of 12-week Milk Fat Globule Membrane Supplementation on the Human Muscle Function of Healthy, Recreationally Active Adults
NCT06573749 ·Status: RECRUITING ·Phase: NA
-
Medium Chain Triglycerides (MCT) and Whey Protein Isolate (WPI) for Type 2 Diabetes Patients (Combine)
NCT04905589 ·Status: COMPLETED ·Phase: NA
-
Protein Source, Nutrition Messaging, and Food Intake
NCT03083145 ·Status: COMPLETED ·Phase: NA
-
Role of Glycaemic Index and High Protein Meal in Response of Blood Biomarkers for Pre-diabetes
NCT03309254 ·Status: COMPLETED ·Phase: NA
-
Balanced (Egg) Protein During Obesity Reduction: Differential Responses of Insulin Resistance by Race
NCT03771261 ·Status: COMPLETED ·Phase: NA
-
The Effect of Whey Protein on Short-Term Food Intake and Post-Meal Blood Glucose Response in Young Men
NCT00988377 ·Status: COMPLETED ·Phase: NA
-
The Body's Response to Food Intake in Older Adults
NCT00798408 ·Status: COMPLETED ·Phase: NA
-
Leucine-enriched Nutraceutical and Attenuating Muscle Loss
NCT03197402 ·Status: COMPLETED ·Phase: NA
-
Modified Whey Protein and Effect on Post Meal Glucose Levels Study
NCT03056677 ·Status: COMPLETED ·Phase: NA
-
Replacing Protein Via Enteral Nutrition in a Stepwise Approach in Critically Ill Patients
NCT03480555 ·Status: COMPLETED ·Phase: NA
-
Whey Protein Effects on Gycemic Control and Vascular Function
NCT01814358 ·Status: WITHDRAWN ·Phase: PHASE1
-
Dietary Protein and Insulin Sensitivity Study
NCT00508937 ·Status: COMPLETED ·Phase: NA
-
Advanced Protein-based Program for Effective Treatment of Appetite Regulation and Obesity
NCT07104461 ·Status: COMPLETED ·Phase: NA